Spotlight on Aggressive Non-Hodgkin Lymphomas (NHL)
June 7, 2023
Join us for a free webinar covering the latest information for patients and caregivers.
To register by phone, call (855) 314-6950.
Topics Covered
We invite you to learn more about:
- Treatment options for aggressive subtypes of non-Hodgkin lymphoma (NHL)
- CAR T-cell therapy for aggressive lymphomas
- Side-effects management
- Questions to ask your healthcare team about treatment options and quality of life issues
Speaker
Jason Westin, MD, MS, FACP
Director, Lymphoma Clinical Research
Section Chief, Aggressive Lymphoma
Department of Lymphoma & Myeloma
The University of Texas at MD Anderson Cancer Center
Houston, TX
Submit a question for Dr. Westin to answer during the Q&A session.
Program Support
Support for this program is provided by Bristol Myers Squibb, Eli Lilly and Company, Genmab US & AbbVie Inc., Incyte Corporation, Kite, A Gilead Company, Merck & Company, and MorphoSys US.